Yazan Abou Ismail Receives The Qatar Foundation Legacy Award
Yazan Abou Ismail, Associate Professor of Hematology at University of Utah, shared on LinkedIn:
”I’m truly humbled and honored to be the recipient of the prestigious Qatar Foundation Legacy Award, selected from among a large, distinguished group of exceptional alumni representing eight universities over three decades of excellence.
On its 30th anniversary, I extend my heartfelt congratulations to the Qatar Foundation on 30 years of visionary leadership, transforming generations of QF Alumni Program through the power of world-class education and state-of-the-art innovation, and building upon the most precious foundation: human potential.
I was unfortunately unable to attend due to travel restrictions, and I remain deeply proud to be a Weill Cornell Medicine – Qatar and QF alumnus, and profoundly grateful to the QF community, led by Her Highness Sheikha, for this honor.
So sad to have missed the opportunity to meet Her Highness!”
More winner stories featured in Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis